Glatiramer acetate is safe and well tolerated in MS patients unable to use interferonbeta therapy

A-M Vallittu, J Peltoniemi, I Elovaara

    Research output: Contribution to journalArticleScientificpeer-review

    Original languageEnglish
    Pages (from-to)234-7
    JournalActa Neurol Scand
    Volume112
    Issue number4
    Publication statusPublished - 2005
    Publication typeA1 Journal article-refereed

    Cite this